Odin Vision Leveraged NVIDIA Inception Program for Startups to Build Cloud-Connected AI Models to Support Endoscopy Odin Vision's AI development efforts were introduced in NVIDIA’s blog
April 22, 2024
NVIDIA logo
Intraoperative Image
TOKYO, April 22, 2024 - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced that Odin Vision 
, a cloud-AI endoscopy company with a strong portfolio of commercially available computer-aided detection and diagnostic solutions and an innovation pipeline of cloud-enabled applications acquired by Olympus in 2023, leveraged the NVIDIA Inception program for cutting-edge startups to build cloud-connected AI models to support polyp characterization and cancer detection during colonoscopy.
For more information, please refer to NVIDIA's blog entry about Odin Vision.
https://blogs.nvidia.com/blog/ai-powered-endoscopy-odin-vision-olympus/
* Products or devices presented include future technology which may be pending regional regulatory approval and are not available for sale in all regions.
* The contents in this website including products availability, specifications or prices are the information as of the date of announcement and are subject to change without prior notice.
* Information is intended to be presented to the media, shareholders, investors, and other interested parties. Information about our medical products (including products currently under development) included in this website is not intended for advertising or medical advice.
* Olympus Corporation assumes no responsibility for any damage resulting from the use of this material.
* All company names and product names mentioned in this website are trademarks or registered trademarks of their respective companies. ® and TM marks are not specified in this website. All trademarks and registered trademarks are the property of their respective owners.